|
|
| | bikaverin Basic information |
| Product Name: | bikaverin | | Synonyms: | bikaverin;6,11-Dihydroxy-3,8-dimethoxy-1-methylbenzo[b]xanthene-7,10, 12-trione;1-Methyl-3,8-dimethoxy-6,11-dihydroxy-12H-benzo[b]xanthene-7,10,12-trione;6,11-Dihydroxy-3,8-dimethoxy-1-methyl-10H-benzo[b]xanthene-7,10,12-trione;Lycopersin;NSC 215139;BRN 0358013;10H-Benzo[b]xanthene-7,10,12-trione, 6,11-dihydroxy-3,8-dimethoxy-1-methyl- | | CAS: | 33390-21-5 | | MF: | C20H14O8 | | MW: | 382.32 | | EINECS: | | | Product Categories: | | | Mol File: | 33390-21-5.mol |  |
| | bikaverin Chemical Properties |
| Melting point | >322℃ | | Boiling point | 429.5°C (rough estimate) | | density | 1.3545 (rough estimate) | | refractive index | 1.4430 (estimate) | | storage temp. | -20°C | | solubility | DMSO: soluble0.5mg/mL (may require sonication and heating) | | form | powder | | pka | 4.13±0.20(Predicted) | | color | Dark red |
| Hazard Codes | T | | Risk Statements | 25 | | Safety Statements | 45 | | RIDADR | UN 2811 6.1 / PGIII | | WGK Germany | 3 | | RTECS | DM2901000 |
| | bikaverin Usage And Synthesis |
| Uses | Bikaverin is a potential inhibitor of HABP with antibiotic, antifungal, and anticancer properties. | | Definition | ChEBI: A organic heterotetracyclic compound that is 10H-benzo[b]xanthene-7,10,12-trione substituted by hydroxy groups at positions 6 and 11, methoxy groups at positions 3 and 8 and a methyl group at position 1. | | storage | +4°C |
| | bikaverin Preparation Products And Raw materials |
|